Please be advised that Cytox Limited was placed into Liquidation on 4 January 2024, with Simon Farr and Anthony Collier of FRP Advisory Trading Limited being appointed Joint Liquidators of the Company. If you are owed money by Cytox Limited, or require further information about the Liquidation, please do not hesitate to contact cpmanchester@frpadvisory.com.
Articles
Articles
Sep 27, 2022
The Journal of Precision Medicine - The Rise of Predictive Genomics
Cytox White Paper - The clinical application of polygenic risk assessment to reduce the risk of cognitive decline in subjects with early cognitive concerns
Cytox White Paper on Assessing Alzheimer’s disease risk using polygenic risk scoring biomarkers
Mar 6, 2017
Cytox’s breakthrough polygenic risk scoring approach for assessing Alzheimer’s disease risk poised to accelerate therapeutic targeting. See BioCentury’s report on ‘Diagnosing AD Trials’